Trulicity also carries a boxed warning that it can potentially cause thyroid C-cell tumors in rats, though its unknown if this risk translates to humans
RUO boundaries matter because research pages should stay focused on laboratory documentation, not personal outcomes or non-research positioning
The main difference between semaglutide and other similar GLP-1 receptor agonists medications, such as Mounjaro (tirzepatide) and Trulicity (dulaglutide), which are circulating on the internet for their weight loss potential, is that Mounjaro and Trulicity are not yet approved by the FDA for medical weight loss in non-diabetic patients
Losing a substantial fraction of it in the process of achieving weight loss is, in metabolic terms, trading one problem for another
Mens Health 12 , 21442151 (2018)
Gulati SC, Gaynor J, Esseesse I, Gee T, Little C, Andreeff M , Berman E, Kempin S, Clarkson B